Table 3.
Total | BD | CNSV | EGPA | GCA | GPA | IgAV | MPA | PAN | TAK | |
---|---|---|---|---|---|---|---|---|---|---|
Identity | 10.7 (5.1) | 13.5 ab (5.3) | 11.7 (4.5) | 10.5 (4.9) | 8.7 a (4.7) | 10.9 (5.2) | 5.7 (3.0) | 10.9 (5.3) | 10.9 (4.0) | 9.2 b (5.0) |
Timeline – acute/chronic | 4.1 (0.8) | 4.2 (0.6) | 4.3 (0.9) | 4.3 (0.8) | 3.7 (0.7) | 4.1 (0.8) | 3.3 (1.0) | 4.0 (0.9) | 4.2 (0.7) | 3.9 (0.9) |
Timeline – cyclical | 3.2 (1.0) | 4.0 abcde (0.6) | 3.4 (1.1) | 3.1 a (0.9) | 3.0 b (0.9) | 3.1 c (1.0) | 3.0 (1.0) | 3.1 d (1.1) | 3.6 (0.9) | 3.2 e (0.8) |
Consequences | 3.8 (0.8) | 4.0 (0.7) | 4.6 (0.4) | 3.9 (0.8) | 3.7 (0.8) | 3.8 (0.8) | 3.1 (0.8) | 3.7 (0.9) | 4.0 (0.8) | 3.9 (0.8) |
Personal control | 3.3 (0.8) | 3.1 (0.7) | 2.8 (0.8) | 3.3 (0.9) | 3.0 (0.8) | 3.3 (0.8) | 3.2 (0.8) | 3.4 (0.7) | 3.2 (0.8) | 3.4 (0.7) |
Treatment control | 3.3 (0.7) | 3.0 (0.7) | 3.0 (1.0) | 3.2 (0.7) | 3.5 (0.7) | 3.4 (0.7) | 3.3 (0.5) | 3.4 (0.7) | 3.2 (0.8) | 3.4 (0.7) |
Emotional representations | 3.1 (1.0) | 3.4 (0.8) | 3.7 (0.9) | 3.2 (1.0) | 3.2 (1.0) | 3.0 (0.9) | 2.8 (0.9) | 3.2 (1.0) | 3.5 (0.9) | 3.0 (0.9) |
Illness coherence | 3.4 (1.0) | 3.2 (1.0) | 3.0 (1.1) | 3.4 (1.0) | 3.3 (1.2) | 3.5 (0.9) | 3.1 (1.1) | 3.3 (1.0) | 3.2 (1.0) | 3.4 (0.9) |
ANOVA was performed to compare means scores across different types of vasculitis types where >30 participants were recruited into the study (i.e. CNSV, IgAV were excluded from comparative analyses due to small sample size). Note a,b,c,d,e denotes row-wise pairs of groups different at 0.05 level Scheffe test. Identity is 0–22 point scale, all other dimensions are scaled 1–5. BD = Behçet’s disease; CNSV = central nervous system vasculitis; EGPA = eosinophilic granulomatosis with polyangiitis (Churg-Strauss); GCA = giant cell arteritis; GPA = granulomatosis with polyangiitis (Wegener’s); IgAV = IgA vasculitis (Henoch-Schönlein); MPA = microscopic polyangiitis; PAN = polyarteritis nodosa; TAK = Takayasu’s arteritis.